Indimed Tempo 19 Indica Concession Entry Tier Medical Cannabis Flower

Indimed Tempo 19 Indica medical cannabis flower

Tempo 19 Indica is a concession entry tier flower from Indimed, developed specifically to give eligible prescribed patients access to a dependable, indica-dominant cultivar at the most affordable price point available within the Little Green Pharma dispensing range. The cultivar delivers a classic earthy and woody aroma with subtle sweet undertones, alongside well-formed buds that carry reasonable trichome coverage for a product at this accessible tier.

Despite its entry-level concession positioning, Tempo 19 Indica is grown under the same core cultivation standards as Indimed’s broader range, meaning patients are not trading away fundamental safety or quality to access the lowest available price point.

This concession entry approach matters for patients managing ongoing conditions on fixed or limited incomes who need consistent access to therapeutic flower without financial strain. Indimed has structured its entry tier specifically around patient need, applying quality and safety benchmarks that ensure Tempo 19 Indica remains a genuinely therapeutic option rather than a compromise product.

For many concession-eligible patients, particularly those newer to medical cannabis or those managing their budgets carefully, this cultivar represents the most practical starting point for an ongoing flower-based treatment plan.

Indimed positions Tempo 19 Indica as a regularly available product within its concession entry tier, with production cycles designed to support consistent national supply for eligible patients. Those who qualify for concession entry pricing are encouraged to discuss this product with their prescriber as a cost-effective foundation for ongoing treatment.

THC percentage

Each batch of Tempo 19 Indica is tested by an independent laboratory, and the certificate of analysis reports total THC content specific to that harvest, targeting the cultivar’s 19 percent THC range. Patients should always refer to the batch-specific COA rather than the general percentage in the product name, since potency can vary slightly between harvests even within a well-maintained genetic line.

Delivering a consistent 19 percent THC target at a concession entry price point is a deliberate part of Indimed’s patient-first approach to this tier, and the cultivation team maintains careful control over flowering time and harvest timing to achieve this outcome across regular production cycles.

Patients managing their dosage closely should keep their COA on file and compare it against previous batches they have used, as this is the most accurate way to track potency changes and adjust dosing in consultation with their prescriber.

Therapeutic Goods Administration cannabis guidanc

CBD percentage

Tempo 19 Indica is primarily cultivated as a THC-dominant cultivar, and its CBD content is generally modest and reported on each batch’s certificate of analysis. Even at lower concentrations, CBD contributes to the overall cannabinoid profile and may play a role in the entourage effect alongside THC and the cultivar’s terpenes.

The quality team tests for CBD alongside THC on every batch to ensure the full cannabinoid picture is available to prescribing doctors and patients. This transparency allows patients to make informed decisions about whether this particular cannabinoid ratio suits their treatment goals.

Patients who require a more balanced or CBD-forward profile should discuss alternative cultivars in the Little Green Pharma range with their prescriber, as Tempo 19 Indica is best suited to those seeking a predominantly THC-driven indica effect.

Terpene profile

The defining feature of Tempo 19 Indica is its classic earthy and woody terpene expression, layered with subtle sweet undertones that give the cultivar the approachable, grounding character typically associated with indica-dominant genetics. Terpenes are responsible for both the aroma and much of the nuanced sensory experience of cannabis, and Indimed applies standardised drying and curing protocols to maintain this profile consistently across production runs even within a concession entry tier framework.

Controlled drying and curing remain important for terpene retention at every price tier, since heat and rushed processing can degrade these compounds quickly regardless of cultivar. The cultivation team manages humidity and temperature carefully during this stage to protect the earthy, woody aromatic profile patients associate with indica-dominant flower.

Each batch’s terpene report, where available, is included alongside the cannabinoid COA so patients can see exactly which terpenes are present in their specific harvest, supporting a more informed approach to selecting flower.

NCBI research on cannabis terpenes

Cultivar lineage

Tempo 19 Indica draws on a stable indica-dominant genetic lineage, selected by Indimed for its dependable earthy terpene character, manageable cultivation requirements, and consistent structural qualities suited to regular production cycles. Its lineage reflects a deliberate selection process favouring genetic stability and repeatable performance over rare or highly specialised phenotypes, which is particularly important for a concession entry product produced at scale.

The indica-dominant background of this cultivar supports the dense bud formation and earthy aromatic profile that patients familiar with indica genetics will recognise, and Indimed has maintained this genetic line specifically for its suitability within a high-frequency, cost-conscious production environment.

Patients who have used Tempo 19 Indica previously can have confidence that each new batch is grown from the same well-maintained genetic stock that underpins its position as the most accessible entry point in the Indimed range.

Batch testing

Every batch of Tempo 19 Indica undergoes independent laboratory testing prior to release, covering cannabinoid potency, terpene content where applicable, and screening for contaminants such as microbials, heavy metals, and pesticide residues. This testing regime is a core part of Little Green Pharma’s quality assurance process and applies equally to concession entry tier cultivars like Tempo 19 Indica as to any other product in the range, ensuring that the lowest price point in the catalogue never comes at the cost of patient safety.

Results are documented in a certificate of analysis that is batch-specific, meaning the figures correspond exactly to the jar a patient receives rather than an average across multiple harvests. This level of traceability matters in a therapeutic context, where dosing accuracy directly affects patient outcomes regardless of price tier.

Patients are encouraged to request or review their batch’s COA and raise any questions about testing results with their prescribing doctor or pharmacist before adjusting their usual dosing routine.

Moisture content

Moisture content is carefully monitored throughout drying and curing to ensure Tempo 19 Indica arrives at an optimal level for both safe storage and consistent inhalation performance. Flower that is too moist is prone to mould risk and uneven burning, while flower that is too dry can lose terpene content and become harsh.

Indimed applies standardised drying schedules across Tempo 19 Indica production to ensure moisture content remains reasonably consistent from batch to batch, supporting a dependable inhalation experience that concession entry patients can rely on at every reorder.

Proper storage after delivery, in a cool, dark, airtight environment, helps maintain the moisture balance achieved during processing, and patients are encouraged to keep flower in its original sealed packaging until ready for use.

Trim quality

Tempo 19 Indica undergoes a quality-controlled trimming process designed to maintain consistent bud presentation across regular production runs. Indimed applies clear quality benchmarks to ensure excess leaf material is removed without significantly compromising trichome coverage, balancing production efficiency with a standard of presentation that remains appropriate for a therapeutic product at every price tier.

This results in buds that are reasonably well presented and structurally consistent from batch to batch, supporting patient confidence in Tempo 19 Indica as a dependable everyday option at the concession entry tier.

Maintaining this trim standard also supports consistent airflow during curing, helping protect the moisture balance and terpene retention discussed above across every production run.

Packaging freshness seal

Tempo 19 Indica is packaged in airtight, light-protective containers fitted with a tamper-evident freshness seal, designed to lock in aroma and protect against light degradation and moisture loss during transit and storage. This packaging standard is applied consistently across the Indimed range, including concession entry tier cultivars, ensuring the flower arrives in the same condition it left the facility regardless of price point.

The seal also provides an additional layer of assurance for patients, confirming the product has not been opened or accessed between leaving the dispensing pharmacy and arriving at the patient’s door.

Patients should inspect the seal upon arrival and retain original packaging for storage to preserve freshness for as long as possible after opening.

Shipping, insurance, and delivery assurance

All orders are covered by insured freight, meaning the value of the shipment is protected in the event of loss or damage during transit, giving patients confidence that their prescribed treatment is financially safeguarded from dispatch to doorstep. Given the prescription nature of this product, deliveries require a signature on delivery, ensuring the package is received directly by the patient or an authorised recipient.

Before any order leaves the dispensing facility, it passes through pre-shipment quality checks, which confirm that packaging seals are intact, labelling is correct, and the product matches the prescription on file. This step exists specifically to catch any issues before they reach the patient.

In the rare event that an issue does occur, a clear damage claim process is available. Patients should photograph the affected packaging and product immediately upon receipt and contact customer support within the stated claim window so the matter can be assessed and resolved promptly.

To explore further concession, value-focused, and standard tier cultivars available for prescribed patients, browse the full dried flower collection at https://littlegreenpharma.shop/product-category/dried-flower-inhalation/

Frequently Asked Questions